FDA cleared the first medical device to treat attention deficit hyperactivity disorder (ADHD) in kids.
Providing another tool to fight the opioid epidemic, FDA cleared the first generic naloxone hydrochloride nasal spray (Narcan) for use in a community setting.
Erdafitinib is first targeted therapy for FGFR3 or FGFR2 genetic alteration.
FDA cleared Dovato (ViiV Healthcare), the first 2-drug regimen to treat HIV-1 in adults with no antiretroviral treatment history.
Metastatic breast cancer drug expands treatment to men.
FDA approved 2 new multiple sclerosis drugs. Here's what you should know about them.
Postpartum drug is a game changer, but can women afford it?
FDA approved a new subcutaneous injection to treat a certain type of early breast cancer.
FDA approved a new generic of Novartis’ Diovan (valsartan) amid a shortage of the blood pressure drug.
Nasal spray offers promise for treatment-resistant depression, but proceed with caution.